Pulmonary tumor thrombotic microangiopathy is an under-recognized cause of pulmonary hypertension and fulminant right ventricle failure associated with high mortality due to delayed diagnosis.
PTTM is a near-fatal, under-recognized cause of pulmonary hypertension and right ventricular failure that requires timely identification.
Absolute Event Rate: 0% vs 0%
Pulmonary tumor thrombotic microangiopathy (PTTM) is an under-recognized cause of pulmonary hypertension and fulminant right ventricle failure. It is associated with a high mortality due to delay in diagnosis. We present two cases of PTTM, both diagnosed postmortem, highlighting the importance of timely identification and initiation of treatment for this near-fatal condition.
Ramakrishnan et al. (Sat,) reported a other. Pulmonary tumor thrombotic microangiopathy is an under-recognized cause of pulmonary hypertension and fulminant right ventricle failure associated with high mortality due to delayed diagnosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: